Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Vildan Kayku Liv Hospital Bahçeşehir Spec. MD. Vildan Kayku Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Chemo for Bladder Cancer: How to Use It Effectively and Powerfully
Chemo for Bladder Cancer: How to Use It Effectively and Powerfully 4

Bladder cancer treatment has changed a lot, giving patients new hope. Chemotherapy is a key part of treatment, mainly for advanced stages.

Learn chemo for bladder cancer usage. A complete guide on how chemotherapy is administered and its role in bladder cancer treatment.

Understanding Bladder Cancer and Its Treatment Landscape

Chemo for Bladder Cancer: How to Use It Effectively and Powerfully
Chemo for Bladder Cancer: How to Use It Effectively and Powerfully 5

Bladder cancer treatment is complex, needing a deep understanding of the disease. It comes in many forms and stages. Each one needs a special treatment plan.

Types and Stages of Bladder Cancer

Bladder cancer is divided into two main types: non-muscle invasive and muscle-invasive. Non-muscle invasive bladder cancer stays in the bladder’s lining. Muscle-invasive bladder cancer goes deeper, possibly spreading to other areas.

The most common bladder cancer type is transitional cell carcinoma, or urothelial carcinoma. It starts in the bladder’s lining cells. Other types include squamous cell carcinoma and adenocarcinoma.

  • Non-muscle invasive bladder cancer (NMIBC)
  • Muscle-invasive bladder cancer (MIBC)
  • Transitional cell carcinoma (urothelial carcinoma)
  • Squamous cell carcinoma
  • Adenocarcinoma

The Role of Chemotherapy in Bladder Cancer Treatment

Chemotherapy is key in treating bladder cancer, mainly for muscle-invasive and advanced cases. It can be given directly into the bladder or through the veins. This depends on the cancer’s stage and the patient’s health.

The choice of chemotherapy method depends on the cancer’s stage and type. Chemotherapy can be used before surgery, after surgery, or as a main treatment for advanced cancer.

Knowing how chemotherapy works in bladder cancer treatment is important. Patients can work with their healthcare team to find the best treatment plan for them.

Chemo for Bladder Cancer: Principles and Mechanisms

Chemo for Bladder Cancer: How to Use It Effectively and Powerfully
Chemo for Bladder Cancer: How to Use It Effectively and Powerfully 6

Chemotherapy is key in treating bladder cancer. It targets fast-growing cancer cells. This treatment uses drugs to kill or stop cancer cells from growing.

How Chemotherapy Targets Cancer Cells

Chemotherapy drugs target cells that grow fast, like cancer cells. Cisplatin and gemcitabine are common drugs for bladder cancer. Cisplatin stops DNA replication in cancer cells. Gemcitabine blocks DNA synthesis, causing cell death.

The success of chemotherapy depends on the cancer’s stage, grade, and the patient’s health.

Timing and Integration with Other Treatments

Chemotherapy is used at different stages of bladder cancer treatment. It can shrink tumors before surgery or kill remaining cells after. It’s also used with radiation therapy to boost its effect.

Choosing the right time and combination of treatments is key. A team of healthcare experts decides the best plan for each patient.

Treatment Goals at Different Disease Stages

The goals of chemotherapy change with the cancer stage. For early-stage cancer, it aims to remove the cancer or prevent it from coming back. In advanced cases, it controls cancer growth, relieves symptoms, and improves life quality.

Disease StageTreatment GoalsChemotherapy Approach
Non-Muscle InvasiveEliminate cancer, prevent recurrenceIntravesical chemotherapy
Muscle InvasiveShrink tumors before surgery, kill remaining cells after surgeryNeoadjuvant or adjuvant chemotherapy
MetastaticControl cancer growth, alleviate symptomsSystemic chemotherapy

Understanding chemotherapy’s role in bladder cancer treatment is vital. By targeting cancer cells and combining treatments, healthcare providers aim for the best outcomes.

Essential Chemotherapy Drugs for Bladder Cancer

Chemotherapy is key in treating bladder cancer. Cisplatin and gemcitabine are two main drugs used.

  • Cisplatin works by messing with DNA, stopping cancer cells from growing.
  • Gemcitabine slows down the growth of cancer cells.

These drugs are often given together. Studies show they can help patients live longer with bladder cancer.

Preparing for Bladder Cancer Chemotherapy

Preparing for chemotherapy is a big step in bladder cancer treatment. It’s important to know what to do before starting treatment. This helps make sure you’re ready and can get the most out of your treatment.

First, talk to your doctor about your treatment plan. They will tell you what to expect and what you need to do. This includes any tests or treatments you might have before starting chemotherapy.

It’s also key to talk about any medicines you’re taking. Some medicines might not be safe with chemotherapy. Your doctor will help you figure out what you can keep taking and what you should stop.

Getting ready for chemotherapy also means thinking about how you’ll manage side effects. Your doctor will tell you about possible side effects and how to deal with them. This might include tips for staying hydrated, managing pain, and taking care of your skin.

It’s a good idea to have a support system in place. Having family, friends, or a support group can help you through tough times. They can offer emotional support and help with daily tasks.

Lastly, make sure you have all the information you need. Keep a list of your medicines, any allergies, and important phone numbers. This can help you stay organized and make sure you get the care you need.

Preparing for chemotherapy is a big step in bladder cancer treatment. By following these steps, you can make sure you’re ready for treatment and can focus on getting better.

Systemic vs. Intravesical Chemotherapy Administration

There are two main ways to give chemotherapy for bladder cancer: systemic and intravesical. The choice depends on the cancer’s stage and type. It also depends on what the treatment aims to achieve.

Intravenous Chemotherapy Protocols

Systemic chemotherapy goes into the body through a vein. This method is used for more serious bladder cancer or when it has spread. It lets the drugs reach all parts of the body.

Key aspects of systemic chemotherapy include:

  • Drugs are given through a vein, usually in the arm.
  • The treatment is given in cycles, with breaks in between.
  • It can cause side effects because it affects cells that grow fast all over the body.

Intravesical Therapy: Direct Delivery to the Bladder

Intravesical chemotherapy puts drugs right into the bladder through a catheter. It’s often used for early bladder cancer that hasn’t gone deep into the muscle.

CharacteristicsSystemic ChemotherapyIntravesical Chemotherapy
Administration MethodIntravenousDirectly into the bladder via catheter
Primary UseAdvanced or metastatic bladder cancerEarly-stage, non-muscle invasive bladder cancer
Side EffectsMore systemic side effectsFewer systemic side effects, more localized

Knowing the differences between systemic and intravesical chemotherapy helps. It helps both patients and doctors choose the best treatment for bladder cancer.

Treating Non-Muscle Invasive Bladder Cancer with Chemotherapy

Intravesical chemotherapy is a key treatment for non-muscle invasive bladder cancer. It involves putting chemotherapy drugs directly into the bladder. This method allows the drugs to reach the tumor more effectively.

Intravesical Treatment Protocols

For non-muscle invasive bladder cancer, doctors use drugs like gemcitabine and mitomycin C. These drugs are put into the bladder weekly for several weeks. This targets cancer cells directly.

The type of drug and how often it’s used can change based on the patient’s needs. Doctors regularly check how well the treatment is working. They make changes as needed.

Recent Innovations with 82% Tumor Elimination Rates

New studies show intravesical chemotherapy can remove up to 82% of tumors. These results come from better drug delivery and new chemotherapy agents.

Improvements in treatment plans, like using more than one drug, have helped. Ongoing research aims to make treatments even better.

Maintenance Therapy Approaches

Maintenance therapy is key in treating non-muscle invasive bladder cancer. It involves ongoing treatment to stop the cancer from coming back. This helps keep the bladder healthy and improves patient outcomes.

Maintenance therapy can include regular chemotherapy drug instillations. For example, treatments might happen every month. The goal is to keep the bladder healthy and prevent cancer from returning.

Neoadjuvant Chemotherapy: Treatment Before Surgery

Neoadjuvant chemotherapy is a key part of treating bladder cancer. It’s given before surgery to improve results. This method is vital for managing the disease well.

Multi-Month Treatment Protocols

Neoadjuvant chemotherapy for bladder cancer lasts several months before surgery. These protocols are carefully designed to maximize treatment benefits while reducing side effects.

Patients get regular checks to see how the chemotherapy is working. Tests and evaluations help figure out the cancer’s response to treatment.

Expected Benefits and Outcome Improvements

The main aim of neoadjuvant chemotherapy is to better bladder cancer treatment outcomes. It makes tumors smaller before surgery. This can make surgery more effective and less invasive.

Studies have shown that neoadjuvant chemotherapy can greatly improve patient outcomes. It can lead to longer survival times and lower cancer recurrence risks.

Monitoring Response to Therapy

It’s important to check how well neoadjuvant chemotherapy is working. Doctors use imaging tests and biopsies to see the cancer’s response.

Based on the patient’s response, the treatment plan can be adjusted. This ensures the best approach is used.

Adjuvant Chemotherapy: Post-Surgical Treatment

Adjuvant Chemotherapy for Bladder Cancer

Adjuvant chemotherapy is a treatment given after the primary therapy to reduce the risk of cancer recurrence. For bladder cancer, it is used to eliminate any remaining cancer cells that may have been left behind after surgery.

Benefits of Adjuvant Chemotherapy

Adjuvant chemotherapy has been shown to improve overall survival and reduce the risk of recurrence in patients with bladder cancer.

Treatment Cycle

The treatment cycle typically consists of a series of chemotherapy sessions, with each session followed by a rest period.

By understanding the role of adjuvant chemotherapy, patients and healthcare professionals can make informed decisions about the best course of treatment.

Advanced Approaches for Metastatic Bladder Cancer

Metastatic bladder cancer is a tough challenge. We need new treatments to help patients. It’s key to know what treatments are available now.

Chemotherapy Options with Survival Rates Under 20%

Chemotherapy is a mainstay in treating metastatic bladder cancer. Some treatments have shown promise. For example, cisplatin-based combination therapies have helped some patients live longer.

“Chemotherapy in metastatic bladder cancer aims to improve life quality and extend life,” says Medical Expert, a top oncologist. “Even though the five-year survival rate is under 20%, some patients do well. Research is ongoing to find these patients.”

Integrating Chemotherapy with Immunotherapy

Combining chemotherapy with immunotherapy is a new hope for metastatic bladder cancer. Immunotherapy drugs like pembrolizumab and atezolizumab have shown good results in trials, even better when paired with chemotherapy.

  • Enhanced response rates
  • Improved overall survival
  • Better tolerability for some patients

This mix of treatments could lead to better results for patients.

Emerging Combination Strategies for Improved Outcomes

Scientists are looking into new combinations of treatments. These include chemotherapy, immunotherapy, and targeted therapies. The goal is to make treatments even better for metastatic bladder cancer patients.

“The future of metastatic bladder cancer treatment is in personalized medicine,” says Medical Expert, a leading cancer researcher. “Therapies will be made to fit each patient’s tumor.”

As we look ahead, using advanced tests and biomarkers will be key. They will help find the best treatments for each patient.

Conclusion: Navigating Your Bladder Cancer Treatment Journey

Dealing with bladder cancer treatment needs a lot of care and support. Patients get the best help from a team of doctors and nurses. They make sure you get all the help you need.

Knowing about chemotherapy is key in bladder cancer care. It’s important to understand all the treatment choices. This way, you can get care that fits your needs, including surgery and immunotherapy.

Good care for bladder cancer is more than just treatment. It’s also about emotional and practical support for patients and their families. We suggest working closely with your healthcare team. This way, you can make a treatment plan that’s just right for you.

FAQ

Q: What is the role of chemotherapy in treating bladder cancer?

Chemotherapy targets and kills cancer cells in bladder cancer. It can be used before surgery to shrink tumors. It can also be used after surgery to kill any remaining cancer cells, or in combination with other treatments.

Q: What are the different types of bladder cancer?

The most common type is urothelial carcinoma, also known as transitional cell carcinoma. Other types include squamous cell carcinoma and adenocarcinoma.

Q: How does chemotherapy work in treating bladder cancer?

Chemotherapy uses medications to kill cancer cells or stop them from growing. It can shrink tumors, reduce symptoms, and improve quality of life in bladder cancer.

Q: What are the common chemotherapy drugs used to treat bladder cancer?

Common drugs include cisplatin, gemcitabine, and mitomycin C.

Q: What is the difference between systemic and intravesical chemotherapy?

Systemic chemotherapy is given through a vein, circulating throughout the body. Intravesical chemotherapy is given directly into the bladder through a catheter.

Q: What are the benefits and risks of chemotherapy for bladder cancer?

Chemotherapy can shrink tumors, reduce symptoms, and improve quality of life. But, it can also cause side effects like nausea, fatigue, and hair loss. There are also risks of long-term effects on fertility and organ function.

Q: How is chemotherapy used in combination with other treatments for bladder cancer?

Chemotherapy is often used with surgery, radiation therapy, or immunotherapy. The treatment plan depends on the cancer’s stage and type, and the patient’s health.

Q: What are the latest developments in chemotherapy for bladder cancer?

New medications and treatment protocols are being developed. This includes combination regimens and targeted therapies.

Q: How can I prepare for chemotherapy treatment for bladder cancer?

To prepare, discuss your treatment plan with your healthcare team. This includes the type and dosage of chemotherapy, side effects, and follow-up care.

Q: What are the possible side effects of chemotherapy for bladder cancer?

Common side effects include nausea, fatigue, hair loss, and changes in appetite or bowel habits. Serious side effects can include neutropenia, anemia, and increased risk of infection.

References

National Center for Biotechnology Information. (2025). How to Use Chemotherapy for Bladder Cancer A.

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Vildan Kayku Liv Hospital Bahçeşehir Spec. MD. Vildan Kayku Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Vildan Kayku Medical Oncology

Spec. MD. Vildan Kayku

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 28 17